Clinical trial
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7
NCT05622162
Study timeline
Study start (actual)2022-12-19Date precision: day
Registry last updated2024-05-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
18F- Fluorocholineunresolved
PSMA PETunresolved
Radiotherapyunresolved
Prostatectomyunresolved
Tumor of Prostateunresolved
Interventions
Sponsors & collaborators
ITEL Telecomunicazioni Srllead sponsor
Advice Pharma Group srlcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05622162 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.